NHI.no
Annonse
Informasjon

Blodpropp i øyet (netthinnen)

Blodpropp i øyet - det vil si tilstopping av hovedarterien til netthinnen, eller til noen av dens grener, medfører akutt og ensidig tap av synet uten noen annen form for ubehag. Det er en akuttsituasjon og krever umiddelbar innleggelse i sykehus.

Blodpropp i øyet vil i løpet av 90 til 100 minutter i de fleste tilfeller føre til uopprettelige skader på netthinnen.

Sist oppdatert:

12. sep. 2022

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Arteriell okklusjon i retinale kar . Referanselisten for dette dokumentet vises nedenfor

  1. Forsaa V, Lindtjørn B. Retinale arterielle okklusjoner. Nasjonal kvalitetshåndbok for oftalmologi. Sist oppdatert 2016. www.helsebiblioteket.no
  2. Varma DD, Cugati S, Lee AW, Chen CS. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond). 2013 Jun; 27(6): 688–697. www.ncbi.nlm.nih.gov
  3. Pokhrel PK, Loftus SA. Ocular emergencies. Am Fam Physician 2007; 76: 829-36. American Family Physician
  4. Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol 2011; 152:820. PubMed
  5. Hedges TR. Central and branch retinal artery occlusion. UpToDate, last updated Oct 09, 2018. UpToDate
  6. Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology 2009; 116:1928. PubMed
  7. Youm DJ, Ha MM, Chang Y, Song SJ. Retinal vessel caliber and risk factors for branch retinal vein occlusion. Curr Eye Res. 2012 Apr. 37:334-8. PMID: 22324736 PubMed
  8. Etminan M, Sodhi M, Mikelberg FS, et al. Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US. JAMA Ophtalmol 2022; 140: 480-484. pmid:35389459 PubMed
  9. Gelston CD, Deitz GA. Eye Emergencies. Am Fam Physician. 2020;102(9):539-545. PubMed
  10. Page PS, Khattar NK, White AC, et al. Intra-arterial thrombolysis for acute central retinal artery occlusion: a systematic review and meta-analysis. Front Neurol. 2018;9:76. PubMed
  11. Rudkin AK, Lee AW, Chen CS. Ocular Neovascularization following Central Retinal Artery Occlusion: Prevalence and Timing of Onset. European Journal of Ophthalmology, 2010; 20(6): 1042–1046.
  12. Fraser SG, Adams W. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD001989. DOI: 10.1002/14651858.CD001989.pub2 DOI
  13. Shahjouei S, Bavarsad Shahripour R, Dumitrascu OM. Thrombolysis for central retinal artery occlusion: An individual participant-level meta-analysis published online ahead of print, 2023 Jul 27. Int J Stroke. 2023. PMID: 37424312 PubMed
  14. Hazin R, Dixon JA, Bhatti MT. Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy? Curr Opin Ophthalmol 2009; 20:210. PubMed
  15. Nowak RJ, Amin H, Robeson K, Schindler JL. Acute Central Retinal Artery Occlusion Treated with Intravenous Recombinant Tissue Plasminogen Activator. J Stroke Cerebrovasc Dis. 2012; 21: 913. PMID: 22349707 PubMed
  16. Dickersin K, Li T. Surgery for nonarteritic anterior ischemic optic neuropathy. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD001538. DOI: 10.1002/14651858.CD001538.pub4 DOI
  17. Wai KM, Knapp A, Ludwig CA, et al. Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion. JAMA Ophtalmol 2023; 141: 1110-1116. pmid:37883068 PubMed
Annonse
Annonse